VIA-2291

· Tallikut Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VIA-2291, covering 2012-07-20 to 2012-07-23. Get the full timeline:

Most recent: Clinical Trial Update: Study Effect of VIA-2291 on Vascular Inflammation [Phase 2]